{
  "trial_id": "NCT00021060",
  "title": "Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer",
  "condition": "Adenocarcinoma of the Lung",
  "participant_count": 842,
  "bias_type": "mixed",
  "age_distribution": {
    "mean": 48.611638954869356,
    "std": 14.858348439749495,
    "min": 18,
    "max": 80
  },
  "gender_distribution": {
    "male": 0.4556514624388062,
    "female": 0.5443485375611938
  },
  "ethnicity_distribution": {
    "white": 0.7,
    "black": 0.15,
    "asian": 0.1,
    "hispanic": 0.04,
    "other": 0.01
  },
  "sample_size": 842,
  "eligibility_score": 0.825237312308537
}